<DOC>
	<DOCNO>NCT02148198</DOCNO>
	<brief_summary>Part 1 study assess effect 1g , 2g 5g dos NWT-03 systolic diastolic blood pressure cross-over design study healthy adult normal , high normal mild hypertension . Based result study , one dose select placebo control parallel study assess single dose NWT-03 systolic diastolic blood pressure endothelial function similar population .</brief_summary>
	<brief_title>Effect NWT-03 Blood Pressure - Part 1</brief_title>
	<detailed_description />
	<criteria>Be able give write informed consent , Be 35 75 year age , Be generally good health determine investigator , Smokers nonsmoker eligible , Have stable body weight ( &lt; 5 % change ) past 3months , Have Body Mass Index ( BMI ) 25 35 kg/m2 , Be : ( ) Normotensive ( Systolic Blood Pressure &lt; 130 mmHg &amp; Diastolic Blood Pressure &lt; 85 mmHg ) , ( b ) High normotensive ( Systolic Blood Pressure 130139 mmHg &amp; Diastolic Blood Pressure 8589 mmHg ) ( c ) Mild hypertensive ( Systolic Blood Pressure 140159 mmHg &amp; Diastolic Blood Pressure 9099 mmHg ) . Are less 35 great 75 year age , Females pregnant , lactate wish become pregnant study . Are hypersensitive component test product , Have significant acute chronic coexist illness cardiovascular disease , Chronic kidney disease ( CKD ) , gastrointestinal disorder , endocrinological disorder , immunological disorder , metabolic disease condition contraindicates , investigator judgement , entry study , Having condition take medication investigator believe would interfere objective study , pose safety risk confound interpretation study result ; include diuretic , blood pressure medication medication interfere reninangiotensinaldosterone system ( RAAS ) , ACEinhibitors , angiotensin receptor blocker , direct renin inhibitor aldosterone receptor inhibitor , Are take nonsteroidal antiinflammatory drug ( NSAIDs ) within 2 week baseline visit duration trial , Suffer diabetes mellitus , either type I type II , Consume recommend alcohol guideline i.e . &gt; 21 alcohol units/week male &gt; 14 units/week female , History illicit drug use , Use nasal decongestant overthe counter herbal preparation within 2 week baseline visit duration trial , Heavy intake coffee ( i.e . 4 cup daily ) within 2 week baseline visit duration trial , Individuals , opinion investigator , consider poor attendee unlikely reason able comply trial , Subjects may receive treatment involve experimental drug , If subject recent experimental trial , must complete less 60 day prior study . An exception make subject participated part 1 study , Have malignant disease concomitant endstage organ disease ,</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>